Abstract
We tested the hypothesis that the negative metabolic effects of elevating cyclic GMP act through inhibition of L-type calcium channels in quiescent cardiac myocytes. The steady state O2 consumption (VO2) of ventricular myocytes, isolated from hearts of New Zealand white rabbits, was measured in a glass chamber using Clark-type oxygen electrodes. The cellular cyclic GMP levels were determined by radioimmunoassay at baseline with either 0.5 mM or 2.0 mM of Ca2+, sodium nitroprusside at increasing concentration (10−8, −6, −4 M) with and without pretreatment by BAY K8644 10−5 M (L-type Ca2+ channel activator) in 0.5 mM Ca2+, or nitroprusside with and without pretreatment with nifedipine 10−4 M (L-type Ca2+ channel blocker) in 2.0 mM Ca2+. In the 0.5 mM Ca2+ medium, basal VO2 was 459±104 (nl O2/min per 105 myocytes) with a corresponding cyclic GMP level of 112±23 (fmol/105 myocytes). With nitroprusside 10−4 M, VO2 was decreased to 285±39 and cyclic GMP level was significantly elevated to 425±128. In the same medium, VO2 was slightly increased by BAY K8644 10−5 M while the cyclic GMP level did not change. With BAY K8644 10−5 M, nitroprusside 10−4 M decreased VO2 and increased cyclic GMP to a level which was similar to cells treated with nitroprusside alone. In the 2.0 mM Ca2+ medium, the basal VO2 and cyclic GMP were 518±121 and 137±24. In the presence of nitroprusside 10−4 M, VO2 was decreased to 295±49 and cyclic GMP was increased to 454±116. In the same medium, nifedipine 10−4 M significantly decreased VO2, while the cyclic GMP level was comparable to the baseline. After nifedipine 10−4 M, nitroprusside 10−4 M decreased VO2 and increased cyclic GMP to levels which were similar to control. Therefore, in quiescent cardiac myocytes, the negative metabolic effects associated with cyclic GMP were not primarily mediated through inhibition of L-type Ca2+ channels.
Similar content being viewed by others
References
Cornell TL, Arnold E, Boerth NJ, Lincoln TM (1994) Inhibition of smooth muscle growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 267:C1405–C1413
Fischmeister R, Hartzell HC (1987) Cyclic guanosine-3′,5′-monophosphate regulates the calcium current in single cells from frog ventricle. J Physiol (Lond) 387:453–472
Fralix TA, Heineman FW, Balaban RS (1991) Effect of work on intracellular calcium of the intact heart. Am J Physiol 261 [Suppl 4]:54–59
Gong GX, Weiss HR, Tse J, Scholz PM (1997) Cyclic GMP decreases cardiac myocyte oxygen consumption to a greater extent under conditions of increased metabolism. J Cardiovasc Pharmacol 30:537–543
Hartzell HC, Fischmeister R (1986) Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells. Nature 323:273–275
Kristein M, Rivet-Bastide M, Hatem S, Benardeau A, Mercadier JJ, Fischmeister R (1995) Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest 95:794–802
Leone R, Naim KL, Scholz PM, Weiss HR (1998) Increased O2 consumption and positive inotropy caused by cyclic GMP reduction are not altered by L-type calcium channel blockade. Pharmacology 56:37–45
Lohmann SM, Fischmeister R, Walter U (1991) Signal transduction by cGMP in heart. Basic Res Cardiol 86:503–514
Matsumoto S (1997) Effect of molsidomine on basal Ca2+ current in rat cardiac cells. Life Sci 60:383–390
Mery PF, Lohmann SM, Walter U, Fischmeister R (1991) Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci 88:1197–1201
Mery PF, Pavoine C, Belhassen L, Pecker F, Fischmeister R (1993) Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268:26286–26295
Moreno-Sanchez R, Hansford RG (1998) Relation between cytosolic free calcium and respiratory rates in cardiac myocytes. Am J Physiol 255:H347–H357
Murad F (1994) The nitric oxide-cGMP signal transduction system for intracellular and intracellular communication. Rec Prog Hormone Res 49:239–248
Ono K, Trautwein W (1991) Potentiation by cyclic GMP of beta-adrenergic effect on Ca2+ current in guinea-pig ventricular cells. J Physiol (Lond.) 443:387–404
Paulus WJ, Vantrimpont PJ, Shah AM (1994) Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation 89:2070–2078
Rose H, Schnitzler N, Kammermeier H (1987) Electrically stimulated cardiomyocytes:evaluation of shortening, oxygen consumption and tracer uptake. Biomed Biochim Acta 8:622–627
Rumsey WL, Schlosser C, Nuutinen EM, Robiolio M, Wilson D (1990) Cellular energetics and the oxygen dependence of respiration in cardiac myocytes isolated from adult rat. J Biol Chem 256:15392–15402
Schmidt HHHW, Lohmann SM, Walter U (1993) The nitric oxide and cGMP signal transduction system:regulation and mechanism of action. Biochim Biophys Acta 1178:153–175
Shah AM, Spurgeon HA, Sollott SJ, Talo A, Lakatta EG (1994) 8-bromo-cGMP reduces the myofilament response to Ca2+ in intact cardiac myocytes. Circ Res 74:970–978
Sperelakis N (1994) Regulation of calcium slow channels of heart by cyclic nucleotides and effects of ischemia. Adv Pharmacol 31:1–24
Sperelakis N, Tohse N, Ohya Y, Masuda H (1994) Cyclic GMP regulation of calcium slow channels in cardiac muscle and vascular smooth muscle cells. Adv Pharmacol 26:217–252
Straznicka M, Gong G, Tse J, Scholz, PM, Weiss HR (1997) The cyclic GMP level which reduces cardiac myocyte O2 consumption is altered in renal hypertension. Am J Physiol 273:H1949–H1955
Sumii K, Sperelakis N (1995) cGMP-dependent protein kinase regulation of the L-type Ca2 current in rat ventricular myocytes. Circ Res 77:803–812
Tohse N, Nakaya H, Takeda Y, Kanno M (1995) Cyclic GMP-mediated inhibition of L-type Ca2+ channel activity by human natriuretic peptide in rabbit heart cells. Br J Pharmacol 114:1076–1082
Weiss HR, Rodriguez E, Tse J, Scholz PM (1994) Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts. Clin Exp Pharmacol Physiol 21:607–614
Weyrich AS, Ma X, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicholas JM, Lefer DJ, Vinten-Johansen J (1994) Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res 75:692–700
Wittenberg BA, Robinson TF (1981) Oxygen requirements, morphology, cell coat and membrane permeability of calcium-tolerant myocytes from hearts of adult rats. Cell Tissue Res 216:231–251
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yan, L., Gong, G.X., Scholz, P.M. et al. Negative metabolic effects of cyclic GMP in quiescent cardiomyocytes are not related to L-type calcium channel activity. Res. Exp. Med. 198, 123–132 (1998). https://doi.org/10.1007/s004330050096
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s004330050096